• Skip to primary navigation
  • Skip to main content
IMMUNOLOGY2023™

IMMUNOLOGY2023™

May 11–15, 2023 | Washington, DC

  • Policy
    • COVID Policy
    • Press Credentials and Policy
  • Program
    • At a Glance
    • By Day
      • Thursday, May 11
      • Friday, May 12
      • Saturday, May 13
      • Sunday, May 14
      • Monday, May 15
    • President’s Program
    • Distinguished Lectures
    • Special Session
    • Major Symposia
    • Committee-Sponsored Sessions
    • Guest Sessions
    • Block Symposia
    • Poster Sessions
    • Award Presentations & Lectures
    • Career Development Opportunities
    • Exhibitor Workshops
    • Social Events
    • Meeting Guide (PDF)
  • For Speakers
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
    • Program Acknowledgements
    • Speaker Disclosures
  • Abstracts
    • View Abstracts Here
    • Poster Presentation Guidelines
    • Podium Presentation Guidelines
    • Submission Guidelines
    • Topic Categories
    • Editing or Withdrawing
    • Publication and Citation
    • Notification of Programming
  • Register
  • Awards
  • Careers
    • Jobs Board
    • For Employers
    • For Job Seekers
  • Hotels
  • Exhibitors
    • Exhibitor Workshops
    • Exhibitors – Start Here
    • Sponsorship
  • Sponsors
  • FAQ
  • Show Search
Hide Search
 Friday, May 12, 2023     12:30 PM – 1:15 PM ET     Exhibit Hall D, Room 1

Exhibitor Workshop: Miltenyi Biotec

Unlock the Full Potential for Your CAR NK Cells

Presenter

  • Jonathan Druge, Jr., Immuno-oncology Applications

Natural killer (NK) cells are a promising tool in the fight against cancer. Allogeneic NK cells derived from suitable donors, showed high-clinical safety and impressive clinical outcomes in patients with acute myeloid leukemia (AML). Further engineering of NK cells with chimeric antigen receptors (CARs) bolsters their antitumor activity and mediates the specific killing of tumor cells. But despite substantial advances, unlocking the full therapeutic potential of CAR NK cells requires investigating their limited persistence, proliferation, and impaired in vivo antitumor activity. As a longtime trusted partner for cell and gene therapy solutions, Miltenyi Biotec is committed to advancing the CAR NK field. During this workshop, we will showcase how our most recent product developments and complete workflows can effectively advance your research and generate scalable and reproducible results. Get insight on how to isolate functional NK cells directly from your blood products, boost your lentiviral transduction efficiency, easily activate and expand your NK cells, and streamline your in-process and quality control (IPC/QC) methods with our latest flow analysis solutions. Join us and unlock the full potential of your CAR NK cells.

All IMMUNOLOGY2023™ attendees are required to comply with the AAI COVID-19 policy.

IMMUNOLOGY2023™
May 11—15, 2023
Walter E. Washington Convention Center
Washington, DC

AAI Courses
JOIN AAI NOW
Publish in The Journal of Immunology
Publish in ImmunoHorizons
Facebook
Twitter
Instagram
TikTok
LinkedIn

IMMUNOLOGY2023™

Copyright © 2025 The American Association of Immunologists, Inc. All rights reserved.

  • FAQ
  • Code of Conduct
  • COVID Policy
  • Press Policy
  • Privacy Policy

Jobs Board submissions for IMMMUNOLOGY2023™ are closed. Please post your jobs on the physical jobs board onsite in the convention center.